Colin A. Stewart

Calgary, AB T2N1N4, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Canadian Hematology Consensus Group Recommendations for the Management of Relapsed and/or Refractory Follicular Lymphoma.

Canadian Hematology Consensus Group Recommendations for the Management of Relapsed and/or Refractory Follicular Lymphoma.

Journal: Current oncology (Toronto, Ont.)
Published: June 06, 2026

Limited diagnostic utility of bone marrow sampling in PET-defined limited-stage follicular lymphoma.

Limited diagnostic utility of bone marrow sampling in PET-defined limited-stage follicular lymphoma.

Journal: British journal of haematology
Published: December 17, 2025

Time spent in healthcare among older patients with primary central nervous system lymphoma treated with high-dose methotrexate.

Time spent in healthcare among older patients with primary central nervous system lymphoma treated with high-dose methotrexate.

Journal: Leukemia & lymphoma
Published: March 11, 2025

De-escalated Induction Therapy and Thiotepa/Busulfan-based Autologous Stem Cell Transplantation for Primary Central Nervous System Lymphoma.

De-escalated Induction Therapy and Thiotepa/Busulfan-based Autologous Stem Cell Transplantation for Primary Central Nervous System Lymphoma.

Journal: Clinical lymphoma, myeloma & leukemia
Published: October 09, 2024

Importance of long-term follow-up of autologous stem cell transplantation for mantle cell lymphoma.

Importance of long-term follow-up of autologous stem cell transplantation for mantle cell lymphoma.

Journal: Leukemia & lymphoma
Published: July 05, 2024

Reappraisal of autologous stem cell transplantation for transformed indolent lymphoma in the bendamustine era.

Reappraisal of autologous stem cell transplantation for transformed indolent lymphoma in the bendamustine era.

Journal: Bone marrow transplantation
Published: May 31, 2024

Autologous transplantation improves survival rates for follicular lymphoma patients who relapse within two years of chemoimmunotherapy: a multi-center retrospective analysis of consecutively treated patients in the real world.

Autologous transplantation improves survival rates for follicular lymphoma patients who relapse within two years of chemoimmunotherapy: a multi-center retrospective analysis of consecutively treated patients in the real world.

Journal: Leukemia & lymphoma
Published: July 04, 2018

The Adverse Consequences of Initial Watchful Waiting for Patients With Follicular Lymphoma.

The Adverse Consequences of Initial Watchful Waiting for Patients With Follicular Lymphoma.

Journal: Clinical lymphoma, myeloma & leukemia
Published: May 08, 2018
Showing 1-8 of 8

Last Updated: 09/26/2026